A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
During the last decade, the underlying pathogenic mechanisms of acute myeloid leukemia (AML) have been the subject of extensive study which has considerably increased our understanding of the disease. However, both resistance to chemotherapy and disease relapse remain the principal obstacles to succ...
Saved in:
Main Authors: | Ying Chen (Author), Jishi Wang (Author), Fengqi Zhang (Author), Ping Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A hypoxia-related genes prognostic risk model, and mechanisms of hypoxia contributing to poor prognosis through immune microenvironment and drug resistance in acute myeloid leukemia
by: Xin Liu, et al.
Published: (2024) -
Immunotherapies for Acute Myeloid Leukemia
Published: (2020) -
Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia
by: Xing Bian, et al.
Published: (2024) -
Advances in the drug therapies of acute myeloid leukemia (except acute promyelocytic leukemia)
by: Lin M, et al.
Published: (2018) -
Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020)